Figure 11.

Additional risk of dying from an upper gastrointestinal bleed or cardiovascular event with celecoxib. For representational purposes an additional risk of 1 in about 100,000 was assumed where there was no numerically increased risk, here for either risk. GI, gastrointestinal. GI, gastrointestinal.

Moore et al. Arthritis Research & Therapy 2008 10:R20   doi:10.1186/ar2373
Download authors' original image